Open AccessSequential Therapies for Proliferative Lupus Nephritis
Author(s) -
Gabriel Contreras,
Victoriano Pardo,
Baudouin Leclercq,
Oliver Lenz,
Elaine Tozman,
Patricia O'Nan,
David A. Roth
Publication year - 2004
Publication title -
new england journal of medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa031855
Subject(s) - cyclophosphamide , medicine , lupus nephritis , azathioprine , gastroenterology , mycophenolate , systemic lupus erythematosus , surgery , urology , chemotherapy , transplantation , disease
Long-term therapy with cyclophosphamide enhances renal survival in patients with proliferative lupus nephritis; however, the beneficial effect of cyclophosphamide must be weighed against its considerable toxic effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom